Home › NDC Lookup › RxCUI directory › RxCUI 1597262

Blinatumomab 0.035 MG Injection — RxCUI 1597262

Name: Blinatumomab 0.035 MG Injection (RxCUI 1597262)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1597262 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1597262

Official nameBlinatumomab 0.035 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asblinatumomab 35 MCG Injection

FDA products mapped1

Package NDCs mapped2

Reported Medicaid activity (SDUD)6,717 prescriptions · 33 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Blinatumomab 0.035 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Blinatumomab 0.035 MG Injection RxCUI 1597262 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Blinatumomab 1597258 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Blincyto 1597263 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Blinatumomab Injection 1651250 SCDF
- Blinatumomab Injectable Product 1597260 SCDG
- Blinatumomab Injection [Blincyto] 1651253 SBDF
- Blincyto Injectable Product 1597266 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Blinatumomab 0.035 MG 1651249 SCDC
- Blinatumomab 0.035 MG Injection [Blincyto] 1597267 SBD
- Blinatumomab 0.035 MG [Blincyto] 1651252 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Blinatumomab 0.035 MG SCDC · 1651249
Blinatumomab Injection SCDF · 1651250
Blinatumomab Injectable Product SCDG · 1597260

Brand-Name Concepts

Blinatumomab 0.035 MG Injection [Blincyto] SBD · 1597267
Blinatumomab 0.035 MG [Blincyto] SBDC · 1651252
Blinatumomab Injection [Blincyto] SBDF · 1651253
Blincyto Injectable Product SBDG · 1597266
Blincyto BN · 1597263

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 1597262 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
55513-0160-01	1 KIT in 1 PACKAGE (55513-160-01) * 3.088 mL in 1 VIAL (55...	BLINCYTO	Amgen, Inc	2014-12-18
55513-0160-21	1 KIT in 1 PACKAGE (55513-160-21) * 3.088 mL in 1 VIAL (55...	BLINCYTO	Amgen, Inc	2026-04-30

Observed labelers: Amgen, Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9039	Injection, blinatumomab	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.